In vivo quantification of the cerebral monoacylglycerol lipase using [18F]T-401
- Conditions
- Healthy subjects, Alzheimer's disease, NSMOD, PSP
- Registration Number
- JPRN-jRCTs031180045
- Lead Sponsor
- Takahata Keisuke
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 23
Healthy male subjects and patients with Alzheimer's disease, NSMOD and PSP
1.Subjects who do not have ability to make informed consent.
2. Subjects with any psychiatric disorder or subjects with severe physical complication.
3. Subjects who currently smokes.
4. Subjects with any organic brain disorder.
5. Subjects with metallic medical device in the body.
6. Subjects with tattoo.
7. Subjects with severe claustrophobia.
8. Subjects with a history of allergy to heparin and local anesthetics.
9. Subjects who has participated in other study in recent 6 months.
10. Subjects who has participated in blood donation in recent 12 weeks.
11. Subjects who is considered to be inappropriate to participate in the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method